Skip to main content
SpringerLink
Log in
Book cover

Perioperative Kidney Injury pp 37–51Cite as

Clinical Pearls: Renal Replacement Therapy for Acute Kidney Injury in the Postoperative Period

  • Chapter
  • First Online:

  • 1240 Accesses

Abstract

The management of perioperative patients with severe acute kidney injury (AKI), and its associated complications, is mostly supportive and includes renal replacement therapy (RRT). Available RRT modalities are intermittent hemodialysis (IHD), peritoneal dialysis (PD), continuous renal replacement therapy (CRRT), and hybrid therapies, known as prolonged intermittent renal replacement therapy (PIRRT). This chapter reviews the current evidence regarding the timing of initiation of RRT, the modality selection, and the critical elements of the RRT prescription for AKI in the postoperative period.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Karvellas CJ, Farhat MR, Sajjad I, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care. 2011;15:R72.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jaber BL. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis. 2008;52:272–84.

    Article  PubMed  Google Scholar 

  3. Selby NM, McIntyre CW. A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant. 2006;21:1883–98.

    Article  PubMed  Google Scholar 

  4. Palevsky PM, O’Connor TZ, Chertow GM, Crowley ST, Zhang JH, Kellum JA. Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study. Crit Care. 2009;13:310.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Emili S, Black NA, Paul RV, Rexing CJ, Ullian ME. A protocol-based treatment for intradialytic hypotension in hospitalized hemodialysis patients. Am J Kidney Dis. 1999;33:1107–14.

    Article  PubMed  CAS  Google Scholar 

  6. Conger J. Dialysis and related therapies. Semin Nephrol. 1998;18:533–40.

    PubMed  CAS  Google Scholar 

  7. Briglia A, Paganini EP. Acute renal failure in the intensive care unit. Therapy overview, patient risk stratification, complications of renal replacement, and special circumstances. Clin Chest Med. 1999;20:347–66. viii.

    Article  PubMed  CAS  Google Scholar 

  8. Paganini EP, Sandy D, Moreno L, Kozlowski L, Sakai K. The effect of sodium and ultrafiltration modelling on plasma volume changes and haemodynamic stability in intensive care patients receiving haemodialysis for acute renal failure: a prospective, stratified, randomized, cross-over study. Nephrol Dial Transplant. 1996;11 Suppl 8:32–7.

    Article  PubMed  Google Scholar 

  9. Steiner RW. Continuous equilibration peritoneal dialysis in acute renal failure. Perit Dial Int. 1989;9:5–7.

    PubMed  CAS  Google Scholar 

  10. Phu NH, Hien TT, Mai NT, et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med. 2002;347:895–902.

    Article  PubMed  Google Scholar 

  11. Cerda J, Ronco C. Modalities of continuous renal replacement therapy: technical and clinical considerations. Semin Dial. 2009;22:114–22.

    Article  PubMed  Google Scholar 

  12. Ronco C, Bellomo R. Basic mechanisms and definitions for continuous renal replacement therapies. Int J Artif Organs. 1996;19:95–9.

    PubMed  CAS  Google Scholar 

  13. Ronco C, Ricci Z. Renal replacement therapies: physiological review. Intensive Care Med. 2008;34:2139–46.

    Article  PubMed  Google Scholar 

  14. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol. 1999;10:846–53.

    PubMed  Google Scholar 

  15. Farese S, Jakob SM, Kalicki R, Frey FJ, Uehlinger DE. Treatment of acute renal failure in the intensive care unit: lower costs by intermittent dialysis than continuous venovenous hemodiafiltration. Artif Organs. 2009;33:634–40.

    Article  PubMed  Google Scholar 

  16. Heering P, Morgera S, Schmitz FJ, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med. 1997;23:288–96.

    Article  PubMed  CAS  Google Scholar 

  17. Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D. Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med. 1996;22:1360–7.

    Article  PubMed  CAS  Google Scholar 

  18. Morgera S, Slowinski T, Melzer C, et al. Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis. 2004;43:444–53.

    Article  PubMed  CAS  Google Scholar 

  19. van Deuren M, van der Meer JW. Hemofiltration in septic patients is not able to alter the plasma concentration of cytokines therapeutically. Intensive Care Med. 2000;26:1176–8.

    Article  PubMed  Google Scholar 

  20. Friedrich JO, Wald R, Bagshaw SM, Burns KE, Adhikari NK. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care. 2012;16:R146.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Fieghen HE, Friedrich JO, Burns KE, et al. The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury. BMC Nephrol. 2010;11:32.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kumar VA, Yeun JY, Depner TA, Don BR. Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report. Int J Artif Organs. 2004;27:371–9.

    PubMed  CAS  Google Scholar 

  23. Kielstein JT, Kretschmer U, Ernst T, et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis. 2004;43:342–9.

    Article  PubMed  CAS  Google Scholar 

  24. Wu VC, Wang CH, Wang WJ, et al. Sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for postsurgical acute renal failure. Am J Surg. 2010;199:466–76.

    Article  PubMed  Google Scholar 

  25. Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007;(18):CD003773.

    Google Scholar 

  26. Bagshaw SM, Berthiaume LR, Delaney A, Bellomo R. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med. 2008;36:610–7.

    Article  PubMed  Google Scholar 

  27. Pannu N, Klarenbach S, Wiebe N, Manns B, Tonelli M. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA. 2008;299:793–805.

    Article  PubMed  CAS  Google Scholar 

  28. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis. 2002;40:875–85.

    Article  PubMed  Google Scholar 

  29. Kellum JA, Angus DC, Johnson JP, et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med. 2002;28:29–37.

    Article  PubMed  Google Scholar 

  30. Schneider AG, Bellomo R, Bagshaw SM, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med. 2013;39:987–97.

    Article  PubMed  CAS  Google Scholar 

  31. Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76:422–7.

    Article  PubMed  Google Scholar 

  32. Baldwin I, Bellomo R, Naka T, Koch B, Fealy N. A pilot randomized controlled comparison of extended daily dialysis with filtration and continuous veno-venous hemofiltration: fluid removal and hemodynamics. Int J Artif Organs. 2007;30:1083–9.

    PubMed  CAS  Google Scholar 

  33. Baldwin I, Naka T, Koch B, Fealy N, Bellomo R. A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance. Intensive Care Med. 2007;33:830–5.

    Article  PubMed  CAS  Google Scholar 

  34. Gabriel DP, Caramori JT, Martim LC, Barretti P, Balbi AL. High volume peritoneal dialysis vs daily hemodialysis: a randomized, controlled trial in patients with acute kidney injury. Kidney Int Suppl. 2008;73:S87–93.

    Article  Google Scholar 

  35. Davenport A. Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis. 2001;37:457–66.

    Article  PubMed  CAS  Google Scholar 

  36. Davenport A. Continuous renal replacement therapies in patients with acute neurological injury. Semin Dial. 2009;22:165–8.

    Article  PubMed  Google Scholar 

  37. Lin CM, Lin JW, Tsai JT, et al. Intracranial pressure fluctuation during hemodialysis in renal failure patients with intracranial hemorrhage. Acta Neurochir Suppl. 2008;101:141–4.

    Article  PubMed  CAS  Google Scholar 

  38. Davenport A. Continuous renal replacement therapies in patients with liver disease. Semin Dial. 2009;22:169–72.

    Article  PubMed  Google Scholar 

  39. Venkataraman R, Kellum JA, Palevsky P. Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States. J Crit Care. 2002;17:246–50.

    Article  PubMed  Google Scholar 

  40. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119:64S–94.

    Article  PubMed  CAS  Google Scholar 

  41. Davenport A, Will EJ, Davison AM. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure. Nephron. 1994;66:431–7.

    Article  PubMed  CAS  Google Scholar 

  42. Martin PY, Chevrolet JC, Suter P, Favre H. Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. Am J Kidney Dis. 1994;24:806–12.

    Article  PubMed  CAS  Google Scholar 

  43. van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol. 1996;7:145–50.

    PubMed  Google Scholar 

  44. Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol. 2006;1:79–87.

    Article  PubMed  CAS  Google Scholar 

  45. Morgera S. Regional anticoagulation with citrate: expanding its indications. Crit Care Med. 2011;39:399–400.

    Article  PubMed  Google Scholar 

  46. Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy–heparin or citrate? Crit Care. 2011;15:202.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Calatzis A, Toepfer M, Schramm W, Spannagl M, Schiffl H. Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron. 2001;89:233–6.

    Article  PubMed  CAS  Google Scholar 

  48. Pinnick RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med. 1983;308:258–61.

    Article  PubMed  CAS  Google Scholar 

  49. Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care. 2005;20:155–61.

    Article  PubMed  CAS  Google Scholar 

  50. Hofmann RM, Maloney C, Ward DM, Becker BN. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF). Ren Fail. 2002;24:325–35.

    Article  PubMed  CAS  Google Scholar 

  51. Cointault O, Kamar N, Bories P, et al. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol Dial Transplant. 2004;19:171–8.

    Article  PubMed  CAS  Google Scholar 

  52. Bihorac A, Ross EA. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition. Am J Kidney Dis. 2005;46:908–18.

    Article  PubMed  CAS  Google Scholar 

  53. Kutsogiannis DJ, Mayers I, Chin WD, Gibney RT. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis. 2000;35:802–11.

    Article  PubMed  CAS  Google Scholar 

  54. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int. 1990;38:976–81.

    Article  PubMed  CAS  Google Scholar 

  55. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med. 2004;30:260–5.

    Article  PubMed  Google Scholar 

  56. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int. 1999;55:1991–7.

    Article  PubMed  CAS  Google Scholar 

  57. Swartz R, Pasko D, O’Toole J, Starmann B. Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Clin Nephrol. 2004;61:134–43.

    Article  PubMed  CAS  Google Scholar 

  58. Tobe SW, Aujla P, Walele AA, et al. A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions. J Crit Care. 2003;18:121–9.

    Article  PubMed  CAS  Google Scholar 

  59. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int. 2001;60:370–4.

    Article  PubMed  CAS  Google Scholar 

  60. Apsner R, Schwarzenhofer M, Derfler K, Zauner C, Ratheiser K, Kranz A. Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr. 1997;109:123–7.

    PubMed  CAS  Google Scholar 

  61. Kramer L, Bauer E, Joukhadar C, et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med. 2003;31:2450–5.

    Article  PubMed  CAS  Google Scholar 

  62. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med. 2001;29:748–52.

    Article  PubMed  CAS  Google Scholar 

  63. Bakker AJ, Boerma EC, Keidel H, Kingma P, van der Voort PH. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Clin Chem Lab Med. 2006;44:962–6.

    Article  PubMed  CAS  Google Scholar 

  64. Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2012;59:810–8.

    Article  PubMed  CAS  Google Scholar 

  65. Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med. 2012;38:20–8.

    Article  PubMed  Google Scholar 

  66. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356:26–30.

    Article  PubMed  CAS  Google Scholar 

  67. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;346:305–10.

    Article  PubMed  Google Scholar 

  68. Saudan P, Niederberger M, De Seigneux S, et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int. 2006;70:1312–7.

    Article  PubMed  CAS  Google Scholar 

  69. Palevsky PM, Zhang JH, O’Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359:7–20.

    Article  PubMed  CAS  Google Scholar 

  70. Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627–38.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Alabama at Birmingham, 1720 2nd Avenue South, ZRB 604, Birmingham, AL, 35294, USA

    Ashita J. Tolwani MD, MSE

  2. Renal Section, VA Pittsburgh Healthcare System, Room 7E123 (111F-U), University Drive, Pittsburgh, PA, 15240, USA

    Paul M. Palevsky MD

  3. Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Paul M. Palevsky MD

Authors
  1. Ashita J. Tolwani MD, MSE
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul M. Palevsky MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul M. Palevsky MD .

Editor information

Editors and Affiliations

  1. Division of Nephrology and Hypertension, University of Cincinnati, Cincinnati, Ohio, USA

    Charuhas V. Thakar

  2. Program of Applied Translational Research, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA

    Chirag R. Parikh

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Tolwani, A.J., Palevsky, P.M. (2015). Clinical Pearls: Renal Replacement Therapy for Acute Kidney Injury in the Postoperative Period. In: Thakar, C., Parikh, C. (eds) Perioperative Kidney Injury. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1273-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1273-5_4

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1272-8

  • Online ISBN: 978-1-4939-1273-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation